Yuji Tabata

This inventor holds 10 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Meiji Seika Kaisha, Ltd., Meiji Seika Pharma Co., Ltd.. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuji Tabata. Retrieved from https://idiyas.com/inventor/yuji-tabata-svhirju0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10

% Patents Active = 90.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 22(Granted Patents)

Location History:

Kanagawa, JP (1998)
Yokohama, JP (1998 - 2020)

Company Filing History:

6 out of 382

Meiji Seika Kaisha, Ltd.

patents

4 out of 107

Meiji Seika Pharma Co., Ltd.

patents

Years Active: 1998-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12239643 - Therapeutic agent for inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases (2025-03-04),

2. 10669283 - Compound and pharmacologically acceptable salt thereof (2020-06-02),

3. 9890142 - PDE4 inhibitor (2018-02-13),

4. 8889727 - Topical antifungal agent (2014-11-18),

5. 6713473 - Tricyclic compounds (2004-03-30),

6. 6255339 - Tetrahydronaphthofuranone derivatives and process for producing the same (2001-07-03),

7. 6077840 - Tetrahydrobenzindolone derivatives (2000-06-20),

8. 5817816 - Sesquiterpene derivatives having progesterone receptor binding (1998-10-06),

9. 5789602 - Physiologically active substances PF1092A, PF1092B and PF1092C, process (1998-08-04),

10. 5712306 - Physiologically active substances PF1092A, PF1092B and PF1092C, and (1998-01-27),

Title: Yuji Tabata: Innovator in Therapeutic Agents

Introduction

Yuji Tabata is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of various diseases. With a total of 10 patents to his name, Tabata's work has had a considerable impact on medical science.

Latest Patents

One of his latest patents focuses on a therapeutic agent for inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases. This innovative therapeutic agent is designed to treat at least one disease selected from a specific group, which includes inflammatory diseases, autoimmune diseases, fibrotic diseases, and cancer diseases. The active ingredient comprises at least one compound represented by a general formula, along with pharmacologically acceptable salts thereof.

Career Highlights

Throughout his career, Yuji Tabata has worked with notable companies such as Meiji Seika Kaisha, Ltd. and Meiji Seika Pharma Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Yasushi Kurata and Takeru Yamakawa. Their collaborative efforts have contributed to the advancement of therapeutic solutions in the medical field.

Conclusion

In summary, Yuji Tabata is a distinguished inventor whose work in therapeutic agents has the potential to transform the treatment of various diseases. His innovative contributions continue to shape the future of medical science.

Profile summary based on public USPTO records.